Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s Becky Knockemus talks with Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA).
"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can...
"In research or in biotech, time is expensive. Time is the most expensive thing that you have." - Stephanie Wisner, Author, Co-Founder at Centivax...
"Patients have already been exposed to these large language models (LLMs). Yes, they are aware of the risks, but they are also very aware...